157 related articles for article (PubMed ID: 2577702)
21. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
22. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the hemodynamic effects of labetalol and sodium nitroprusside in patients undergoing carotid endarterectomy.
Geniton DJ
AANA J; 1990 Aug; 58(4):281-7. PubMed ID: 2399780
[TBL] [Abstract][Full Text] [Related]
24. Post-carotid endarterectomy hypertension: association with elevated cranial norepinephrine.
Ahn SS; Marcus DR; Moore WS
J Vasc Surg; 1989 Feb; 9(2):351-60. PubMed ID: 2645444
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
26. Acute hemodynamic and neurohumoral profile of dilevalol in hypertensive patients with ischemic heart disease.
Remme WJ; von Schelven D; Bartels GL; Kruijssen HA; de Leeuw PW
J Cardiovasc Pharmacol; 1993 Aug; 22(2):327-35. PubMed ID: 7692177
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
Ohman KP; Weiner L; von Schenck H; Karlberg BE
Eur J Clin Pharmacol; 1985; 29(2):149-54. PubMed ID: 3908121
[TBL] [Abstract][Full Text] [Related]
28. Oral labetalol versus oral clonidine in the emergency treatment of severe hypertension.
Atkin SH; Jaker MA; Beaty P; Quadrel MA; Cuffie C; Soto-Greene ML
Am J Med Sci; 1992 Jan; 303(1):9-15. PubMed ID: 1728876
[TBL] [Abstract][Full Text] [Related]
29. Plasma catecholamines, renin and aldosterone during combined alpha- and beta- adrenoceptor blockade in patients with severe arterial hypertension.
Kornerup HJ; Pedersen EB; Pedersen A; Pedersen G; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():49-52. PubMed ID: 7001422
[TBL] [Abstract][Full Text] [Related]
30. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
[TBL] [Abstract][Full Text] [Related]
31. Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.
Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
Eur J Clin Pharmacol; 1979 Nov; 16(5):305-10. PubMed ID: 520398
[TBL] [Abstract][Full Text] [Related]
32. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
33. Labetalol in the treatment of hypertension in elderly and younger patients.
Abernethy DR; Bartos P; Plachetka JR
J Clin Pharmacol; 1987 Nov; 27(11):902-6. PubMed ID: 2892866
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
35. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
Malesker MA; Hilleman DE
J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
[TBL] [Abstract][Full Text] [Related]
36. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
[TBL] [Abstract][Full Text] [Related]
37. Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension.
Ehikioya E; Okobi OE; Beeko MAE; Abanga R; Abah NNI; Briggs L; Nwimo PN; Beeko PKA; Nwachukwu OB; Okoroafor CC
Cureus; 2023 Jul; 15(7):e42332. PubMed ID: 37614273
[TBL] [Abstract][Full Text] [Related]
38. I.v. labetalol in the treatment of hypertension following coronary-artery surgery.
Morel DR; Forster A; Suter PM
Br J Anaesth; 1982 Nov; 54(11):1191-6. PubMed ID: 7138722
[TBL] [Abstract][Full Text] [Related]
39. Treatment of severe hypertension with intravenous labetalol.
Papademetriou V; Notargiacomo AV; Khatri IM; Freis ED
Clin Pharmacol Ther; 1982 Oct; 32(4):431-5. PubMed ID: 7116758
[TBL] [Abstract][Full Text] [Related]
40. The response of plasma catecholamines to intravenous labetalol: a comparison with sodium nitroprusside.
Lin MS; McNay JL; Shepherd AM; Keeton TK
Clin Pharmacol Ther; 1983 Oct; 34(4):466-73. PubMed ID: 6617068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
